These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11063834

  • 1. Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis.
    Im SH, Barchan D, Fuchs S, Souroujon MC.
    J Neuroimmunol; 2000 Nov 01; 111(1-2):161-8. PubMed ID: 11063834
    [Abstract] [Full Text] [Related]

  • 2. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.
    Im SH, Barchan D, Fuchs S, Souroujon MC.
    J Clin Invest; 1999 Dec 01; 104(12):1723-30. PubMed ID: 10606626
    [Abstract] [Full Text] [Related]

  • 3. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC.
    J Immunol; 2001 Jun 01; 166(11):6893-8. PubMed ID: 11359850
    [Abstract] [Full Text] [Related]

  • 4. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ, Chae CS, So JS, Tzartos SJ, Souroujon MC, Fuchs S, Im SH.
    Mol Immunol; 2008 Nov 01; 46(1):192-201. PubMed ID: 18799218
    [Abstract] [Full Text] [Related]

  • 5. Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors.
    Souroujon MC, Maiti PK, Feferman T, Im SH, Raveh L, Fuchs S.
    Ann N Y Acad Sci; 2003 Sep 01; 998():533-6. PubMed ID: 14592924
    [Abstract] [Full Text] [Related]

  • 6. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
    Im SH, Barchan D, Souroujon MC, Fuchs S.
    J Immunol; 2000 Oct 01; 165(7):3599-605. PubMed ID: 11034361
    [Abstract] [Full Text] [Related]

  • 7. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD, Bai XF, Li HL, Huang YM, Van der Meide PH, Link H.
    Clin Exp Immunol; 1998 Mar 01; 111(3):506-12. PubMed ID: 9528890
    [Abstract] [Full Text] [Related]

  • 8. Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis.
    Feferman T, Im SH, Fuchs S, Souroujon MC.
    J Neuroimmunol; 2003 Jul 01; 140(1-2):153-8. PubMed ID: 12864983
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment.
    Maiti PK, Feferman T, Im SH, Souroujon MC, Fuchs S.
    J Neuroimmunol; 2004 Jul 01; 152(1-2):112-20. PubMed ID: 15223243
    [Abstract] [Full Text] [Related]

  • 10. Protective molecular mimicry in experimental myasthenia gravis.
    Im SH, Barchan D, Feferman T, Raveh L, Souroujon MC, Fuchs S.
    J Neuroimmunol; 2002 May 01; 126(1-2):99-106. PubMed ID: 12020961
    [Abstract] [Full Text] [Related]

  • 11. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS, Adikari SB, Huang YM, Link H, Xiao BG.
    Neurobiol Dis; 2004 Jul 01; 16(2):461-7. PubMed ID: 15193302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X, Zhao J, Kong Q, Xie X, Wang J, Sun B, Xu L, Mu L, Li H.
    Immunol Invest; 2018 Oct 01; 47(7):712-724. PubMed ID: 29944018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.
    Luo J, Kuryatov A, Lindstrom JM.
    Ann Neurol; 2010 Apr 01; 67(4):441-51. PubMed ID: 20437579
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells.
    Xiao BG, Duan RS, Link H, Huang YM.
    Cell Immunol; 2003 May 01; 223(1):63-9. PubMed ID: 12914759
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D, Asher O, Tzartos SJ, Fuchs S, Souroujon MC.
    Eur J Immunol; 1998 Feb 01; 28(2):616-24. PubMed ID: 9521072
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
    Zhang GX, Xiao BG, Yu LY, van der Meide PH, Link H.
    J Neuroimmunol; 2001 Feb 01; 113(1):10-8. PubMed ID: 11137572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.